Compare Agilent Technologies Inc (A) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Liberty Global Ltd Class C — how do they compare? Agilent Technologies Inc trades at $129.21 (market cap $37.04B), while Liberty Global Ltd Class C trades at $10.33 (market cap $3.60B). The key difference: Agilent Technologies Inc is far larger — about 10.3× Liberty Global Ltd Class C's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Liberty Global Ltd Class C pays none. Which is the better fit depends on your goals.
| A | LBTYK | |
|---|---|---|
Market Cap | $37.04B | $3.60B |
Sector | Health | Technology |
52-Week High | $157.20 | $12.67 |
52-Week Low | $110.24 | $10.07 |
Enterprise Value | $38.59B | $10.89B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
LBTYK trades at $10.50, down 3.67% today, with a bearish technical signal and mixed fundamentals. The company reported a net loss of $7.14B in 2025 despite $4.88B revenue, though recent Q1 2026 earnings beat expectations. Analyst sentiment remains positive with 69% buy ratings, while technical indicators show resistance at $11 and support at $10.
The outlook hinges on the planned 2027 Ziggo Group spin-off, which could unlock value, but persistent losses and high debt-to-asset ratio of 38.39% pose significant risks. Near-term catalysts include Q2 2026 results in July, with the stock offering speculative upside if operational improvements materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
